Answers are grounded in this paper and cite their sources.
A targeted drug delivery system based on AuNPs and DNA was developed to treat neuroblastoma cancer. This system exhibits excellent specificity in delivering and releasing doxorubicin, and has great prospects in clinical applications.
No takes yet. Share an insight, caveat, or question.
Du et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: